Connected digital products have steadily become more prominent among clinical research efforts since the start of the millennium, according to new data published Friday in NPJ Digital Medicine.
In reviewing every trial registered with ClinicalTrials.gov between the years 2000 and 2017, a group of Harvard researchers found the use of these tools increasing with a compound annual growth rate (CAGR...
By
PsychU
03:02 pm
April 7, 2020
A group of organizations—Amazon, Apple, and Google among others—are blurring the line between the tech field and the healthcare field. One of the key elements in this blurring of the line is the automation of health and human service functions that previously required human work.
This tech-enabled automation is frequently accomplished through bots, which are computer applications that perform...
Earlier this week Cellex became the first company to gain an FDA Emergency Use Authorization for a serology test. The test was designed to identify specific antibodies in the blood linked to coronavirus, which means it can be used to identify past coronavirus infections.
Before this test, the products on the market were designed to detect or diagnose if someone currently has the virus. ...
Nordic startup SideKickHealth is working with the COVID-19 response team in Iceland to provide its digital therapeutics platform to people who have been diagnosed with the virus.
Its platform allows the remote triaging and managing of large numbers of people in isolation, who self-report on a panel of symptoms and measurements via a smartphone app multiple times a day.
Patients are assessed via...
The coronavirus is spreading around the world exponentially. Governments, healthcare providers, and businesses are introducing drastic measures to slow down the spreading of the virus.
There is a strong belief among digital health providers that their services can be of great help now. There are already more than 800 million users of digital health services globally, including symptom checkers,...
These have been turbulent times for the FDA. On the one hand, the U.S. regulator has found itself carefully unravelling guidances to bolster COVID-19 testing and treatment – sometimes leading to confusion for companies searching for new ways to combat the global epidemic. On the other, the agency continues to push forward with broader initiatives to remap its processes so that novel software...
MyHeritage, a genealogy and health DNA testing company, has teamed up with the Beijing Genomics Institute (BGI) to establish a COVID-19 testing lab in its home country of Israel, the Jerusalem Post reported on Saturday. The facility is aiming to open its doors by April 9 with a 10,000-tests-per-day capacity, and hopes to scale up to 20,000 per day shortly after.
“BGI will ship to Israel in the...
Yesterday, Pear Therapeutics announced the regulatory clearance of Somryst, its prescription digital therapeutic for chronic insomnia. And while the product is noteworthy for these patients and Pear's broader business, it also stands as a major milestone for the digital health industry – the first product to be evaluated throught the FDA's Digital Health Software Precertification Program.
Now...
Pear Therapeutics announced this morning that Somryst, its prescription digital therapeutic for adults with chronic insomnia, has received marketing authorization from the FDA.
The treatment provides cognitive behavioral therapy for insomnia (CBTi) alongside personalized, algorithm-generated sleep restriction recommendations. The digital therapeutic was reviewed through the agency's 510(k)...
A Dubai-based entrepreneur has backed a British biotech research company currently working on an affordable vaccine to protect against COVID-19.
Khurram Shroff, chairman of the UAE’s IBC Group, has donated a total of AED 5 million ($1.36m) to Vaxbio, also joining the company as a strategic advisor to assist with the development and communication of its corporate initiatives.
Vaxbio, a research...
